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Background: The study evaluated the predictors and the impact of subclinical elevation of cardiac troponin I (cTnI) after PCI on long-term 
cardiovascular outcome in patients (pts) with type II diabetes mellitus (T2DM).
Methods: Fourty-eight consecutive pts with T2DM aged 66.7 ± 6.1 underwent successfully elective stenting of single coronary lesions. Real-time 
microembolization during PCI was assessed as high-intensity transient signals (HITS) using a Doppler guide wire (Volcano). Peak cTnI was measured 
at 24 h after PCI. Pts were followed up for 2 years recording major cardiac events (MACE: death, MI, target vessel - TVR and non-target vessel 
revascularization - nTVR).
Results: In 47of 48 pts HITS were found during PCI. After excluding 5 pts with side branch impairment, a pathologic cTnI > 0.12 ng/ml (median 
0.39 ng/ml) occurred in 19 pts. HITS correlated with peak cTnI (r = 0.43, p = 0.003). A HITS number > 25 predicted a major cTnI elevation > 1 ng/
ml (100% sensitivity, 83% specificity, p = 0.002). At 2-year follow-up MACE were found in 8 pts: MI - 2 pts, nTVR - 5 pts and TVR - 1 pt., who had had 
significantly higher baseline microembolization (27 ± 17 HITS vs. 15 ± 10, p=0.012) and myonecrosis (0.62 ± 0.85 vs. 0.16 ± 0.25 cTnI, p=0.01). 
HITS, but not cTnI, predicted later MACE ( 67 % sensitivity, 73 % specifity for HITS > 25, p= 0.028, Fig.).
Conclusions: Microembolization during PCI in diabetics appears to be an indicator of atherosclerotic burden, associated with both acute 
biomarker elevation and adverse long-term outcomes.
 
